Indeed, a study on human circulating biomarkers of FTD published in 2015 reported an increase in the levels of plasmatic IL‐6 in 230 patients with FTD, independently of the clinical and genetic subtypes [71]. This evidence concerns the gene IL6 and frontotemporal dementia.